
TY  - JOUR
TI  - Poster Sessions
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 39
IS  - S1
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200990224
DO  - doi:10.1002/eji.200990224
SP  - S55
EP  - S279
PY  - 2009
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 60
IS  - S2
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.16336
DO  - doi:10.1111/epi.16336
SP  - 5
EP  - 248
PY  - 2019
ER  - 

TY  - JOUR
TI  - Administrative Operations
JO  - Transfusion
VL  - 47
IS  - s3
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2007.01507_2.x
DO  - doi:10.1111/j.1537-2995.2007.01507_2.x
SP  - 217A
EP  - 279A
PY  - 2007
ER  - 

TY  - JOUR
TI  - Proceedings of the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Miami Beach, USA, November 20–23, 2014
JO  - The Journal of Sexual Medicine
JA  - J Sex Med
VL  - 12
IS  - S2
SN  - 1743-6095
UR  - https://doi.org/10.1111/jsm.12808
DO  - doi:10.1111/jsm.12808
SP  - 101
EP  - 183
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 31
IS  - S2
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.26688
DO  - doi:10.1002/mds.26688
SP  - S1
EP  - S697
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Reproduction in Domestic Animals
JA  - Reprod Dom Anim
VL  - 53
IS  - S2
SN  - 0936-6768
UR  - https://doi.org/10.1111/rda.13272
DO  - doi:10.1111/rda.13272
SP  - 100
EP  - 215
PY  - 2018
ER  - 

TY  - JOUR
AU  - Cui, Liang
AU  - Lu, Haitao
AU  - Lee, Yie Hou
TI  - Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases
JO  - Mass Spectrometry Reviews
JA  - Mass Spec Rev
VL  - 37
IS  - 6
SN  - 0277-7037
UR  - https://doi.org/10.1002/mas.21562
DO  - doi:10.1002/mas.21562
SP  - 772
EP  - 792
KW  - disease
KW  - liquid chromatography
KW  - mass spectrometry
KW  - medicine
KW  - metabolomics
KW  - untargeted metabolomics
PY  - 2018
AB  - In the past decade, advances in liquid chromatography-mass spectrometry (LC-MS) have revolutionized untargeted metabolomics analyses. By mining metabolomes more deeply, researchers are now primed to uncover key metabolites and their associations with diseases. The employment of untargeted metabolomics has led to new biomarker discoveries and a better mechanistic understanding of diseases with applications in precision medicine. However, many major pertinent challenges remain. First, compound identification has been poor, and left an overwhelming number of unidentified peaks. Second, partial, incomplete metabolomes persist due to factors such as limitations in mass spectrometry data acquisition speeds, wide-range of metabolites concentrations, and cellular/tissue/temporal-specific expression changes that confound our understanding of metabolite perturbations. Third, to contextualize metabolites in pathways and biology is difficult because many metabolites partake in multiple pathways, have yet to be described species specificity, or possess unannotated or more-complex functions that are not easily characterized through metabolomics analyses. From a translational perspective, information related to novel metabolite biomarkers, metabolic pathways, and drug targets might be sparser than they should be. Thankfully, significant progress has been made and novel solutions are emerging, achieved through sustained academic and industrial community efforts in terms of hardware, computational, and experimental approaches. Given the rapidly growing utility of metabolomics, this review will offer new perspectives, increase awareness of the major challenges in LC-MS metabolomics that will significantly benefit the metabolomics community and also the broader the biomedical community metabolomics aspire to serve.
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology SIOP 2007: Contents and Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 49
IS  - 4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.21342
DO  - doi:10.1002/pbc.21342
SP  - 398
EP  - 605
PY  - 2007
AB  - Abstract The Full online issue can be found at http://www.interscience.wiley.com/jpages/1545-5009/suppmat
ER  - 

TY  - JOUR
TI  - Oral Presentations and Posters
JO  - Tissue Antigens
JA  - Tissue Antigens
VL  - 85
IS  - 5
SN  - 0001-2815
UR  - https://doi.org/10.1111/tan.12557
DO  - doi:10.1111/tan.12557
SP  - 301
EP  - 431
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Diseases of the Esophagus
JA  - Dis Esophagus
VL  - 27
IS  - S1
SN  - 1120-8694
UR  - https://doi.org/10.1111/dote.12287
DO  - doi:10.1111/dote.12287
SP  - 3A
EP  - 168A
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 17
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.277
DO  - doi:10.1002/ejhf.277
SP  - 5
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral abstracts
JO  - Journal of Diabetes Investigation
JA  - J Diabetes Investig
VL  - 9
IS  - S1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.12938
DO  - doi:10.1111/jdi.12938
SP  - 19
EP  - 46
PY  - 2018
ER  - 

TY  - JOUR
AU  - Yang, Zhongmeng
AU  - Tang, Yuxing
AU  - Lu, Huading
AU  - Shi, Bo
AU  - Ye, Yongheng
AU  - Xu, Guoyong
AU  - Zhao, Qing
TI  - Long non-coding RNA reprogramming (lncRNA-ROR) regulates cell apoptosis and autophagy in chondrocytes
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 119
IS  - 10
SN  - 0730-2312
UR  - https://doi.org/10.1002/jcb.27057
DO  - doi:10.1002/jcb.27057
SP  - 8432
EP  - 8440
KW  - apoptosis
KW  - cell viability
KW  - long non-coding RNA ROR
KW  - p53
KW  - osteoarthritis
PY  - 2018
AB  - Abstract Long Non-Coding RNA Reprogramming (lncRNA-ROR) plays an important role in regulating various biologic processes, whereas the effect of lncRNA-ROR in osteoarthritis (OA) is little studied. This study aimed to explore lncRNA-ROR expression in articular cartilage and identify the functional mechanism of lncRNA-ROR in OA. OA cartilage tissues were obtained from 15 OA patients, and 6 normal cartilage tissues were set as controls. Chondrocytes were isolated from the collected cartilage tissues. lncRNA-ROR was knockdown in normal cells and overexpressed in OA cells. Cell viability was determined with Cell Counting Kit-8 assay, and apoptosis was measured using flow cytometric analysis. Moreover, proteins and mRNAs involved in this study were also measured using Western blotting and quantitative real-time PCR (qPCR). Level of lncRNA-ROR was decreased in OA compared with normal chondrocytes, and overexpression of lncRNA-ROR dramatically promoted cell viability of OA chondrocytes. In addition, knockdown lncRNA-ROR inhibited apoptosis and promoted autophagy of normal chondrocytes. Moreover, lncRNA-ROR inhibited the expression of p53 in both mRNA and protein levels. Furthermore, we revealed that lncRNA-ROR regulated apoptosis and autophagy of chondrocytes via HIF1α and p53. The results indicated that lncRNA-ROR played a critical role in the pathogenesis of OA, suggesting that lncRNA-ROR could serve as a new potential therapeutic target for OA.
ER  - 

TY  - JOUR
AU  - Ghosh, Dhimankrishna
AU  - Yan, Xiaowei
AU  - Tian, Qiang
TI  - Gene regulatory networks in embryonic stem cells and brain development
JO  - Birth Defects Research Part C: Embryo Today: Reviews
JA  - Birth Defects Research Part C: Embryo Today: Reviews
VL  - 87
IS  - 2
SN  - 1542-975X
UR  - https://doi.org/10.1002/bdrc.20149
DO  - doi:10.1002/bdrc.20149
SP  - 182
EP  - 191
KW  - embryonic stem cells (ESCs)
KW  - gene regulatory network (GRN)
KW  - neural stem cells (NSCs)
KW  - glioma
KW  - induced pluripotent stem cells (ips)
PY  - 2009
AB  - Abstract Embryonic stem cells (ESCs) are endowed with the ability to generate multiple cell lineages and carry great therapeutic potentials in regenerative medicine. Future application of ESCs in human health and diseases will embark on the delineation of molecular mechanisms that define the biology of ESCs. Here, we discuss how the finite ESC components mediate the intriguing task of brain development and exhibit biomedical potentials to cure diverse neurological disorders. Birth Defects Research (Part C) 87:182?191, 2009. ? 2009 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - The 2015 Annual Meeting of the International Genetic Epidemiology Society
JO  - Genetic Epidemiology
JA  - Genet. Epidemiol.
VL  - 39
IS  - 7
SN  - 0741-0395
UR  - https://doi.org/10.1002/gepi.21916
DO  - doi:10.1002/gepi.21916
SP  - 529
EP  - 599
PY  - 2015
ER  - 

TY  - JOUR
TI  - Late Breaking Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 69
IS  - s99
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12479
DO  - doi:10.1111/all.12479
SP  - 573
EP  - 619
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Diseases of the Esophagus
JA  - DISEASES OF THE ESOPHAGUS
VL  - 29
IS  - S1
SN  - 1120-8694
UR  - https://doi.org/10.1111/dote.12528
DO  - doi:10.1111/dote.12528
SP  - 3A
EP  - 162A
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 21
IS  - S1
SN  - 1756-1841
UR  - https://doi.org/10.1111/1756-185X.13361
DO  - doi:10.1111/1756-185X.13361
SP  - 23
EP  - 236
PY  - 2018
ER  - 

TY  - JOUR
TI  - American Society of Pediatric Hematology/Oncology 23rd Annual Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 54
IS  - 6
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.22516
DO  - doi:10.1002/pbc.22516
SP  - 787
EP  - 864
PY  - 2010
ER  - 

TY  - JOUR
TI  - 20th Annual Meeting of the Wound Healing Society SAWC/WHS Joint Meeting
JO  - Wound Repair and Regeneration
VL  - 18
IS  - 2
SN  - 1067-1927
UR  - https://doi.org/10.1111/j.1524-475X.2010.00581.x
DO  - doi:10.1111/j.1524-475X.2010.00581.x
SP  - A8
EP  - A52
PY  - 2010
ER  - 
